A spontaneous nonhuman primate model of inherited retinal degeneration
Inherited retinal degenerations (IRDs) are important causes of progressive, irreversible blindness. Hereditary macular diseases, in particular, are significant in their effect on the specialized, central cone photoreceptor-rich macula responsible for high resolution vision. Autosomal dominant Best vitelliform macular dystrophy (BVMD), caused by variants in the BEST1 gene, is one of the most common inherited macular dystrophies. Gene therapies have emerged as promising treatments for IRDs, but a lack of suitable animal models has hindered progress both in treatments and in understanding the mechanisms underlying macular diseases. Here, we report a Macaca fascicularis carrying a heterozygous potential pathogenic BEST1p.Q327E variant that disrupts the BEST1 ion channel by destabilizing the A195 helix, mirroring the structural perturbations seen in certain human pathological mutants. Longitudinal imaging over 2 years revealed progressive macular changes, including subfoveal cleft enlargement, lipid-rich deposit accumulation, retinal pigment epithelium (RPE) disruption, and central-to-peripheral photoreceptor degeneration, recapitulating early human BVMD pathology. Histopathology demonstrated diminished BEST1 expression, attenuation of the RPE-photoreceptor interface, and 2 distinct types of lipid deposits, including heretofore unappreciated cone mitochondrial-enriched lesions, highlighting selective cone mitochondria vulnerability. This is, to our knowledge, the first nonhuman primate model of inherited macular dystrophy, and it links BEST1 mutations, mitochondrial dysfunction, and progressive macular degeneration, offering new insights into BVMD pathophysiology and highlighting its utility for studying disease progression and potential therapeutic interventions.
Authors
- Lingli Zhou (ORCID: https://orcid.org/0000-0002-9321-9348)
- Ziqi Yang (ORCID: https://orcid.org/0000-0001-7555-1083)
- Wenjie Qing (ORCID: https://orcid.org/0009-0005-4497-7010)
- Elia J. Duh (ORCID: https://orcid.org/0000-0003-1917-373X)
- Shoudeng Chen (ORCID: https://orcid.org/0000-0002-7634-2141)
- Yi Wei (ORCID: https://orcid.org/0000-0003-1982-3501)
- Xialin Liu (ORCID: https://orcid.org/0000-0003-2086-5805)
- Zehui Sun
- Le Shi (ORCID: https://orcid.org/0000-0003-3611-7801)
- Yang Zhou (ORCID: https://orcid.org/0000-0002-1148-0666)
- Xiaomei Mai
- Yuying Li (ORCID: https://orcid.org/0000-0003-3704-590X)
- Mingming Xu
- Ying Xue (ORCID: https://orcid.org/0000-0002-2021-065X)
- Kaiwen Zhang (ORCID: https://orcid.org/0000-0001-7518-5191)
- Yingxue Cao
- Lechun Ou
- Aolun Qing
Institutions
- Johns Hopkins University (US)
- Sun Yat-sen University (CN)
- Nantong University (CN)
- Johns Hopkins Medicine (US)
- Affiliated Hospital of Nantong University (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- JCI Insight
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1172/jci.insight.190807
- Citations
- 4
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- National Natural Science Foundation of China
- National Institutes of Health
- Guangzhou Municipal Science and Technology Project
- National Key Research and Development Program of China